Citations

Clear

4610 citation(s) found for "Lu, Brian".

Factors Associated With More Medication Trials Before Surgical Evaluation and Postsurgical Outcomes in Pediatric Drug-Resistant Epilepsy
Samanta, Debopam , Newell, Grace, Caraway, Avery Robert, Brock, Emily, Albert, Gregory W. , Novotny, Edward J. , Cabacar, Dewi Frances Depositario, Gaillard, William D. , Tatachar, Priyamvada , Bolton, Jeffrey , Romanowski, Erin Fedak , Alexander, Allyson , Auguste, Kurtis I. , Bernardo, Danilo , Ostendorf, Adam P. , Karia, Samir , Karakas, Cemal , Pichon, P, Olaya, Joffre , Shrey, Daniel W. , Reddy, Shilpa B. , Ganesh, Abhinaya, Hauptman, Jason S. , Singh, Rani K. , Ciliberto, Michael A. , Marashly, Ahmad , Nangia, Srishti, Arredondo, Kristen H. , Miller, D. , Sattar, Shifteh , Montenegro, Maria Augusta , Agarwal, Nitin , Galán, Fernando , Wagner, Janelle L. , Knox, Andrew , Perry, Μ. Scott , Caraway, Avery R. , Caraway, Avery Robert , Novotny, Edward J , Depositario Cabacar, Dewi Frances , Oluigbo, Chima O , Gaillard, William D , Tatachar, Priyamvada , Bolton, Jeffrey Brian , Wong-Kisiel, Lily C. , Fedak Romanowski, Erin , McNamara, Nancy A , Eschbach, Krista , Alexander, Allyson L , Auguste, Kurtis I , Gonzalez-Giraldo, Ernesto , Bernardo, Danilo , Ostendorf, Adam P , Coryell, Jason , Karia, Samir , Karakas, Cemal , Javarayee, Pradeep K , Pichon, Pilar D , Shrey, Daniel W , Reddy, Shilpa B , Ganesh, Abhinaya , Hauptman, Jason , Singh, Rani K , Ciliberto, Michael A , Marashly, Ahmad , Grinspan, Zachary , Arredondo, Kristen H , Miller, Derryl J , Montenegro, Maria , Agarwal, Nitin , Galan, Fernando N , Abel, Taylor J , Knox, Andrew T , Perry, Michael Scott , Newell, Grace, Brock, Emily, Oluigbo, Chima , Wong‐Kisiel, Lily C. , McNamara, Nancy , Eschbach, Krista , Gonzalez‐Giraldo, Ernesto , Coryell, Jason , Javarayee, Pradeep , Grinspan, Zachary M. , Abel, Taylor J.

Mayo Clinic

Neurology | October 7, 2025 | Volume: 105 | Issue: 9 | Pages: No page available

10.1212/wnl.0000000000214198 | PMID 41056528 Get It

Evaluating the impact of an AI cancer prediction platform on early interception of the five deadliest cancers: A retrospective study using real-world data.
Dadhania, Seema , Bakshi, Bea, Herrick, Brian, Raoof, Sana , Haddad, Tufia C. , Payling, Miles, Patel, Tushar , Riaz, Irbaz Bin

Mayo Clinic

JCO Oncology Practice | October 7, 2025 | Volume: 21 | Issue: 10_suppl | Pages: 560-560

10.1200/op.2025.21.10_suppl.560 Get It

560 Background: Early diagnosis remains a critical challenge in oncology, particularly for the five deadliest cancers: lung, breast, prostate, colorectal, and pancreatic. These cancers often present with nonspecific symptoms, leading to repeated healthcare visits without a timely suspicion of malignancy. Artificial intelligence (AI) offers an opportunity to augment clinical decision-making and support earlier identification of cancer. C the Signs , an AI cancer prediction platform, has been widely adopted across the UK with substantial evidence supporting its ability to identify cancer at earlier stages. Methods: This retrospective study assessed the performance of C the Signs in intercepting cancer earlier than physician diagnosis. De-identified electronic medical records were accessed via the Mayo Data Platform, spanning a 20-year period from January 1, 2002 to December 31, 2021. The study cohort included 55,375 patients diagnosed with lung, breast, prostate, colorectal or pancreatic cancer. The primary outcome was the proportion of cases identified earlier by the AI model, measured in annual increments up to five years prior to physician diagnosis. Additional analyses were conducted across the five target cancer types. Results: The C the Signs platform identified 14,528 patients (26.2%) with cancer earlier than the original physician diagnosis. Early identification occurred across multiple time points: 8.9% in year 1, 4.7% in year 2, 4.4% in year 3, 4.3% in year 4, and 3.9% in year 5. Across cancer types, the highest early interception rate was observed in prostate cancer (31.7%), while breast cancer showed the lowest impact (21.0%). Conclusions: Use of the C the Signs AI cancer prediction platform demonstrated meaningful improvements in early cancer interception, particularly for lung and prostate cancers. These findings highlight the potential of AI tools to enhance early diagnosis and support timely clinical interventions, offering a scalable solution to improve cancer outcomes across populations.
Outcomes of Early-Life Focal Cortical Dysplasia–Related Epilepsy
Cohen, Nathan T. , Depositario‐Cabacar, Dewi, Ostendorf, Adam P. , Wong‐Kisiel, Lily C. , Romanowski, Erin Fedak , McNamara, Nancy , Tatachar, Priyamvada , Eschbach, Krista , Alexander, Allyson , Pichon, P, Ciliberto, Michael A. , Bernardo, Danilo , Auguste, Kurtis I. , Arredondo, Kristen H. , Reddy, Shilpa B. , Ganesh, Abhinaya, Marashly, Ahmad , Singh, Rani K. , Bolton, Jeffrey , Karia, Samir , Karakas, Cemal , Lin, Jenny , Knox, Andrew , Samanta, Debopam , Armstrong, Dallas , Pavuluri, Spriha , Hyslop, Ann , Galán, Fernando , Miller, D. , Hauptman, Jason S. , Caraway, Avery Robert, Perry, Μ. Scott , Caraway, Avery R. , Oluigbo, Chima O , Ostendorf, Adam P , Wong-Kisiel, Lily C. , Fedak Romanowski, Erin , McNamara, Nancy A , Tatachar, Priyamvada , Eschbach, Krista , Alexander, Allyson L , Pichon, Pilar D , Ciliberto, Michael A , Gonzalez-Giraldo, Ernesto , Bernardo, Danilo , Auguste, Kurtis I , Coryell, Jason , Arredondo, Kristen H , Novotny, Edward J , Reddy, Shilpa B , Ganesh, Abhinaya , Marashly, Ahmad , Javarayee, Pradeep K , Singh, Rani K , Bolton, Jeffrey Brian , Grinspan, Zachary , Karia, Samir , Karakas, Cemal , Lin, Jenny , Knox, Andrew T , Wolf, Steven , Abel, Taylor J , Samanta, Debopam , Armstrong, Dallas Michael , Hyslop, Ann , Galan, Fernando N , Miller, Derryl J , Hauptman, Jason , Caraway, Avery Robert , Perry, Michael Scott , Gaillard, William D , Oluigbo, Chima , Gonzalez‐Giraldo, Ernesto , Coryell, Jason , Novotny, Edward J. , Javarayee, Pradeep , Grinspan, Zachary M. , Wolf, Steven M. , Abel, Taylor J. , Gaillard, William D.

Mayo Clinic

Neurology Clinical Practice | October 6, 2025 | Volume: 15 | Issue: 6 | Pages: No page available

10.1212/cpj.0000000000200539 | PMID 41070137 Get It

A Step Toward Modernization of Urologic Training: Incorporation of a Novel Surgical Intelligence Platform for Robotic Prostatectomy Video Review
Henning, Grant M., Cohen, Tal , McLeay, Matthew T. , Potretzke, Aaron M. , Koo, Kevin , Boorjian, Stephen A. , Tollefson, Matthew K. , Linder, Brian J. , Khanna, Abhinav, Henning, Grant , Basourakos, Spyridon P. , Potretzke, Aaron M , Koo, Kevin , Viers, Boyd R. , Henning, Grant M , Linder, Brian J , Henning, Grant M., Findlay, Bridget L.

Mayo Clinic

Journal of Endourology | October 6, 2025 | Volume: 39 | Issue: 11 | Pages: 1204-1210

10.1177/08927790251371728 | PMID 40865538 Get It

Purpose: Surgical video review can be used in urologic training, yet significant barriers to the implementation of video review programs exist, and formal assessment of usage and utility for trainees is limited. Here, we evaluate a novel video review platform to describe patterns of use and determine perceived utility. Materials and Methods: We analyzed learning points entered by trainees during video review of radical prostatectomy cases using our surgical intelligence–enabled Film Room platform between September 2023 and July 2024. Learning point content was categorized according to surgical coaching domains as technical, cognitive, nontechnical, or descriptive. Entries were compared by surgical step and level of training. Anonymous surveys were distributed to trainees to determine perceived utility and reveal patterns of video review. Results: Thirteen trainees entered 480 unique learning points across all radical prostatectomy steps and spanning surgical coaching domains during the study period. Learning points varied by training level, with junior trainees entering points more often than senior trainees for Retzius-space dissection ( N = 73 vs 17, p < 0.01) and seminal vesicle and posterior dissection ( N = 58 vs 27, p < 0.01). Trainees used video review in preparation for both upcoming cases and performance analysis. Ninety-four percent of survey respondents reported they either agreed or strongly agreed that video review helped them develop surgical skills. Conclusions: We found usage across training levels and high perceived utility of our Film Room platform for video review of robotic prostatectomy. Implementation of video review platforms holds promise to augment existing urologic training and should be explored further.
B-018 Evaluation of a biological safety cabinet enclosed liquid handler for use in automating sterile cell culture preparation for T cell proliferation assays
Dukek, Brian A. , Swanson, Jay, Exsted, Michael, Isham, Crescent R., Tschanz, Tyler, Baumann, N, Kumánovics, Attila , Swanson, Jay

Mayo Clinic

Clinical Chemistry | October 2, 2025 | Volume: 71 | Issue: Supplement_1 | Pages: No page available

10.1093/clinchem/hvaf086.416 Get It

Abstract Background Lymphocyte function and immune competence can be measured by proliferative response to stimuli and is useful in several clinical contexts including primary (or genetic) and secondary immunodeficiencies (e.g., immunosuppression following transplantation). Proliferation assays have traditionally been prepared manually due to the difficulty in maintaining the sterile environment required to prevent bacterial and fungal impact on cell growth. On most automated liquid handlers, the sample and reagents are placed inside a cabinet whose inner surfaces include rails, pullies, pumps, and circuitry that face the sample and are not amenable to sterilization. The Andrew+ (Waters, MA) is a small surface cleanable liquid handler with all machinery enclosed. We demonstrate here the use of an Andrew+ placed in a biological safety cabinet (BSC) to perform sterile assay setup. Methods Peripheral blood monocytes (PBMCs) from five individuals were manually generated via buffy coat isolation, then brought to standardized concentration. An Andrew+ was placed in a 4’ BSC and all surfaces disinfected with Oxivir Tb (Diversey, SC). The Andrew+ prepared three serial dilutions of two stimulant reagents (phytohemagglutinin (PHA) and pokeweed (PWM)), then dispensed stimulant and control reagents horizontally and PBMCs vertically to a 48 well plate. This process was duplicated manually from the same specimens to create a reference plate. The plates were incubated at 37°C and 5% CO2 for three days, then pulsed with EdU (Thermo Fisher, MA) and incubated for one additional day. Cells were harvested and counted via flow cytometry. Overall time and hands-on time were measured. Results A total of five samples were tested inside a using both manual and automation setup under eight conditions including with isotype control, media without stimulant, three concentrations of PHA, and three concentrations of PWM. The percent proliferation for various cell types as induced by each stimulant was calculated from the difference of the highest stimulant signal from the background (media-only) signal. Comparing the automated and manual method results showed a slope of 1.0217 and R2 of 0.9966. For a simulated run of 6 samples, technologist time for automated steps was under 8 minutes with a total time of 56 minutes. When these steps were performed manually, the time was 30 minutes. Automation increased total time by 26 minutes but saved 22 minutes of technologist hands-on time. Conclusion The Andrew+ was able to perform sterile setup of a cell culture assay. While slower overall than manual processing, technologist time was reduced. Ergonomic, inter-tech variability, and sample transcription error issues were subjectively observed to be less likely. The Andrew+ can work with up to four “dominos” (reagent or tip blocks) in width and up to three dominos in depth. Non-custom, standard depth BSCs from a variety of manufacturers (Labconco, Nuaire, ThermoFisher) have room for one domino in depth so, except for timings performed in this evaluation, all steps were broken down to be performed with a max of four dominos. Efficient sterile use of the system would require an extended depth BSC.
Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical Trials
Hage, Chadi A. , Goldberg, Hilary J. , Patel, Mrunal, Reynolds, John M. , Klesney‐Tait, Julia , Arcasoy, Selim M. , Naik, Chetan , Simone, Nicole De , Usmani, Amena , Girgis, Reda E. , Cordova, Francis , Patil, Jagadish , Morrell, Matthew R. , Lendermon, Elizabeth A. , Huang, Howard J. , Peláez, Andrés, Emtazoo, Amir, Wille, Keith , Chan, Kevin M. , Yung, Gordon , Baz, M., Aryal, Shambhu , Derfler, Mary Clare, Commean, Paul K., Berman, Keith, Прокудин, А. В. , Despotis, George J. , Group, on the behalf of the EPI Study, Baz, Maher, Hachem, Ramsey R. , Byers, Derek E. , Walia, Rajat , Keller, Brian C. , Nunley, David R. , Baz, Maher, Vedantham, Suresh , Atkinson, Andrew , Atkinson, Jeffrey J. , Prokudin, Alexey, McCarthy, John Edward , Group, on the behalf of the EPI Study

Mayo Clinic

Transplantation | October 1, 2025 | Volume: 110 | Issue: 2 | Pages: e481-e491

10.1097/tp.0000000000005515 | PMID 41032890 Get It

Background. The spirometric response to standard-of-care (SOC) immunosuppressive therapy for the management of bronchiolitis obliterans syndrome (BOS) has been sparsely reported in the literature. Data from a Medicare-approved Registry were analyzed to characterize the effectiveness/durability of a wide range of SOC interventions to manage the decline of lung function and to validate the study spirometric criteria for initiation of rescue therapy. Methods. Lung transplant recipients with refractory BOS at 21 US collaborating centers were enrolled in the Registry. Data included both nonspirometric (eg, demographic, Immunosuppressive Regimens for management of BOS) and spirometric parameters (ie, forced expiratory volume in 1 s [FEV 1 ] measurements and derived indices). The utility of study FEV 1 criteria for treatment (ie, statistically significant rate of FEV 1 decline >30 mL/mo) was evaluated by comparing the spirometric course between participants who met or did not meet this criterion. Results. Only 21% of participants treated with SOC therapy had >50% decrease (76 ± 25% decrease) in the rate of FEV 1 decline. Although 51% of participants had a partial response (rate of FEV 1 decline decreased on average 71%), 49% of participants had a substantial increase (mean increase 224%). The FEV 1 criterion for treatment was able to identify 19% of participants (48/258) who achieved durable stabilization (ie, nonsignificant rate of FEV 1 <30 mL/mo) with SOC therapy. Conclusions. Patients with BOS have a widely variable response to SOC therapy. Our findings support the use of FEV 1 rate of decline to assess response to SOC therapy and to ensure appropriate assignment of participants with refractory BOS to rescue therapy treatment cohorts.
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia
Pai, Sher‐Lu , Nimma, Sindhuja, Beam, William B. , VanderWielen, Beth A. , Bettini, Layne M., Collaborators, MAGIC (Mayo Anesthesia Gastric Imaging Collaborative), Logvinov, Ilana I. , Nimma, Sindhuja R, Beam, W Brian, Kalagara, Hari K., Yu, Soojie , Pai, Sher-Lu , Logvinov, Ilana , Kalagara, Hari , Sharpe, Emily E. , Harbell, Monica W. , Collaborators, MAGIC (Mayo Anesthesia Gastric Imaging Collaborative)

Mayo Clinic

Anesthesia & Analgesia | October 1, 2025 | Volume: 142 | Issue: 4 | Pages: 640-649

10.1213/ane.0000000000007764 | PMID 41032460 Get It

BACKGROUND: The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has significantly increased in recent years. GLP-1 RAs delay gastric emptying, resulting in early satiety and weight loss. This may increase the risk of pulmonary aspiration of residual gastric contents (RGC) during anesthesia delivery. Evidence is urgently needed to guide perioperative anesthesia management for patients taking GLP-1 RAs. This study evaluated preoperative factors that may be associated with high RGC. METHODS: Adult patients who were taking GLP-1 RAs and scheduled to receive anesthesia at 3 hospitals between June 30, 2023, and August 15, 2024, were evaluated via preoperative point-of-care gastric ultrasonography (GUS). The primary outcome was high RGC, defined by the presence of solids food or >1.5 mL/kg of clear liquids on GUS, and its association with preoperative factors (eg, existing medical conditions, indication and route of taking GLP-1 RAs, length of taking GLP-1 RAs, days of withholding GLP-1 RAs before surgery, and preoperative fasting periods). Data are presented as median (interquartile range [IQR]). RESULTS: Among the 316 patients (60.9 years [52.1–68.9] of age; 167 [52.8%] females) included in the study, 113 (35.8%) had high RGC. A higher percentage (5.3%; 6/113) of patients in the high RGC group had an opioid prescription for pain management within 3 months of the GUS assessment compared to the low RGC group (1.0%; 2/203; P = .027). No statistical difference was found between the groups in other existing medical conditions, indication and route of taking GLP-1 RAs, and length of taking GLP-1 RAs. Of the 294 patients taking weekly injections, there were 187 (63.6%) with low RGC and 107 (36.4%) with high RGC. Patients with low RGC withheld their GLP-1 RAs for 8 days [5–10], while patients with high RGC withheld for 6 days [3–9] ( P = .003). Receiver operating characteristic (ROC) analysis found ≤7.5 days of withholding the medication as cutoff for increased prevalence of high RGC in patients taking GLP-1 RA injections. Patients with low RGC fasted from solid food for 20.0 hours [14.8–40.8], and patients with high RGC fasted from solid food for 15.0 hours [12.8–19.0] ( P < .001). ROC found ≤21.3 hours of fasting from solid food as the cutoff for increased prevalence of high RGC. CONCLUSIONS: GLP-1 RA usage may delay gastric emptying. In preoperatively fasting adults, ≤7.5 days of withholding injections and ≤21.3 hours of fasting from solid food are associated with high RGC.
Teaching AI for Radiology Applications: A Multisociety‑Recommended Syllabus from the AAPM, ACR, RSNA, and SIIM
Kitamura, Felipe , Kline, Timothy L. , Warren, Daniel , Santos, Igor , Bialecki, Brian , O'Donnell, Kevin , Morgan, Matthew B. , Safdar, Nabile , Andriole, Katherine P. , Geis, J. Raymond , Dreyer, Keith J. , Wood, Monica J. , Langer, Steve G., Farina, Eduardo Moreno Júdice de Mattos , Reiser, Ingrid , Wald, Christoph , Cook, Tessa S. , Tenenholtz, Neil , Kline, Timothy, Langer, Steve, Kitamura, Felipe C , Reiser, Ingrid , Moy, Linda , Daneshjou, Roxana , Maleki, Farhad , Gichoya, Judy Wawira , Wiggins, Walter F. , Flanders, Adam E , Allen, Bibb , Lungren, Matt , Kohli, Marc , Shih, George , Kahn, Charles E. , Giger, Maryellen , Mongan, John

Mayo Clinic

Medical Physics | October 1, 2025 | Volume: 52 | Issue: 10 | Pages: No page available

10.1002/mp.17779 | PMID 41030223 Get It

Abstract Medical imaging is undergoing a transformation driven by the advent of new, highly effective, machine learning techniques paired with increases in computational capabilities (Cheng et al. 2021; Gilson et al. 2023; Almeida et al. 2024; Krishna et al. 2024). These advanced algorithms have the potential to improve disease detection, diagnosis, prognosis, and treatment outcomes. However, the complexity of machine learning models, the large amounts of curated and annotated data required by some methods, and the potential for bias and error make it challenging for individuals to safely and effectively leverage these methods (Lin et al. 2024; Guo et al. 2024; Xu et al. 2024; Linguraru et al. 2024; Wood et al. 2019). To address these challenges, the American Association of Physicists in Medicine (AAPM), American College of Radiology (ACR), Radiological Society of North America (RSNA), and Society for Imaging Informatics in Medicine (SIIM) have worked together to develop a syllabus detailing a recommended set of competencies for medical imaging professionals interacting with these systems. This guide is aimed at four different personas: users of AI systems, purchasers of AI systems, individuals who provide clinical expertise during the development of AI systems (“clinical collaborators”), and developers of AI systems.1 This is a syllabus, not a curriculum, and is intentional in this scope. Recognizing that individuals may benefit from different presentations of the same material, this work enumerates a series of relevant competencies but does not prescribe, nor offer, a method of instruction (Schuur, Rezazade Mehrizi, and Ranschaert 2021; Garin et al. 2023). By addressing the task‐specific demands of each role, this guide will enable medical imaging professionals to utilize machine learning systems more safely and effectively, ultimately improving patient care and outcomes.